Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.30 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.30 |
| ▸ | CCR5 | P51681 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | EEF2K | O00418 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21049596 | 0.98 | GNAI3 (0.33) | CES2CES1GNAI3GNAI1CCR5 | |
| SCHEMBL21049621 | 0.98 | GNAI3 (0.33) | CES2CES1GNAI3GNAI1CCR5 | |
| SCHEMBL21049599 | 0.89 | — | — | |
| SCHEMBL22188978 | 0.84 | EEF2K (0.41) | CES2CES1CCR5EEF2K | |
| SCHEMBL22189129 | 0.80 | EEF2K (0.35) | MEN1KMT2AEEF2K | |
| SCHEMBL22189101 | 0.77 | CA2 (0.41) | L3MBTL1MEN1KMT2ATDP1 | |
| SCHEMBL21049551 | 0.69 | — | — | |
| Trifluoroacetic Acid SCHEMBL7967266 | 0.68 | CCR5 (0.43) | CES2CES1CCR5MEN1KMT2A | |
| SCHEMBL21049532 | 0.68 | EEF2K (0.37) | CES2CES1CCR5EEF2K | |
| SCHEMBL4516642 | 0.67 | EEF2K (0.38) | EEF2K |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3604287-B1 | PRODUCTION METHOD FOR AMIDATE COMPOUND | KOEI CHEMICAL CO (JP) | 2022-08-03 | — | — | EP | disclosed |
| EP-3495353-B1 | AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN | KOEI CHEMICAL CO (JP) | 2021-11-17 | — | — | EP | disclosed |
| US-10689478-B2 | Amidate compound, catalyst for polyurethane production, and method for producing polyurethane resin | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2020-06-23 | — | — | US | disclosed |
| EP-3604287-A1 | PRODUCTION METHOD FOR AMIDATE COMPOUND | Koei Chemical Company, Limited (JP) | 2020-02-05 | — | — | EP | disclosed |
| US-20190177464-A1 | AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2019-06-13 | — | — | US | disclosed |
| EP-3495353-A1 | AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN | Koei Chemical Company, Limited (JP) | 2019-06-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10689478-B2 | Amidate compound, catalyst for polyurethane production, and method for producing polyurethane resin | ARG1, NIT2, RER1 | L3MBTL1 1977/4885CES2 1806/4885CES1 1753/4885 |
| US-20190177464-A1 | AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN | ARG1, NIT2, RER1 | L3MBTL1 1977/4885CES2 1806/4885CES1 1753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.